SAMSUNG BIOLOGICS
LIVE

Serial Number

90380563

Owner

SAMSUNG C&T CORPORATION

Attorney

Diane J. Mason

Filing Date

Dec 14, 2020

Add to watchlist:

No watchlists yet
View on USPTO

SAMSUNG BIOLOGICS Trademark

Serial Number: 90380563 • Registration: 7102687

SAMSUNG BIOLOGICS is a trademark filed by SAMSUNG C&T CORPORATION on December 14, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

SAMSUNG C&T CORPORATION (126 trademarks)

310, 2-KA
CHUNG-KU, SEOUL, , KR

Entity Type: 99

Trademark Details

Filing Date

December 14, 2020

Registration Date

July 11, 2023

Published for Opposition

April 25, 2023

Goods & Services

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; Treatment of biopharmaceutical materials, namely, processing finished products from raw biopharmaceutical materials; Production of cell lines for use in the manufacture of biopharmaceuticals; chemical treatment of liquids; processing of medicinal materials, namely, custom manufacturing of pharmaceuticals; Custom manufacture of pharmaceuticals for others; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of medical products; processing of chemicals

Bouillons for bacteriological cultures; biological reagents for veterinary purposes; biological tissue cultures for veterinary purposes; diagnostic test reagents for medical or veterinary purposes; in vitro diagnostic preparations for medical purposes; biological preparations for medical or veterinary purposes for the prevention and treatment of infectious diseases; reagents and media for medical and veterinary diagnostic purposes; cultures of microorganisms for medical or veterinary use; diagnostic preparations for medical and veterinary use; cultures for medical use, namely, bacteriological cultures for medical purposes; biological reagents for medical purposes; biological tissue cultures for medical purposes; stem cells for medical purposes; stem cells for medical, pharmaceutical or veterinary use; surgical implants grown from stem cells being living tissues; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis for medical or veterinary purposes; radioisotope markers for therapeutic or diagnostic use

Enzymes derived from biotechnological processes for use in industry; cell growth media for growing cells for use in scientific research; stem cells for scientific purposes; cells for scientific or laboratory purposes; preparations for gene recombination for scientific or laboratory purposes; synthetic gene for research other than for medical purposes; chemicals for use in biotechnological product development; biological preparations for use in biotechnology other than for medical or veterinary use; biological tissue cultures, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; probiotic bacterial cultures for the food industry; stem cells for research purposes; chemical reagents for use in genetic research; chemical reagents for genetic identity testing for non-medical purposes; stem cells other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purpose; reagents for use in scientific apparatus for chemical or biological analysis

Microbial culture trials; research and development of technology for biotechnology; crude medicines research, namely, Herbal medicine research; biochemistry research services; bacteriological research and analysis; development of cell therapy products; development of pharmaceutical preparations and medicines; pharmaceutical products development; inspection of pharmaceuticals; research relating to pharmaceuticals; clinical testing of medicines; pharmaceutical products evaluation; scientific research in the field of genetic engineering; Genetic research for scientific purposes; medical laboratories; Medical research of medicines; research for medical products; Conducting clinical trials for others; stem cell research services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 11, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 11, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 25, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 25, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 5, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 21, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2023 CRFA
ASSIGNED TO LIE
Mar 11, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 29, 2022 ERSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 15, 2022 RCCK
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 11, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 11, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 11, 2022 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 3, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 3, 2022 GNSL
SUSPENSION LETTER WRITTEN
Jan 3, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 14, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 14, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 14, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 18, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jun 18, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jun 18, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 5, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 22, 2021 NWOS
NEW APPLICATION ENTERED
Dec 17, 2020 NWAP